Comparison of Two Salpingectomy Techniques for Sterilization at the Time of Cesarean Delivery
Launched by INOVA HEALTH CARE SERVICES · Feb 14, 2024
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different techniques for performing a surgical procedure called salpingectomy, which is a method of permanent sterilization, during a cesarean delivery (C-section). The trial aims to compare the outcomes and costs of using a hand-held device that uses heat (bipolar energy) versus the traditional method that uses stitches to close the fallopian tubes. Researchers want to find out if one technique works better than the other in the short term.
To participate in this study, women must be at least 21 years old, be 24 weeks pregnant or more, and request permanent sterilization during their C-section. They should also meet specific health requirements, such as not having had certain prior surgeries or specific pregnancy complications. If eligible, participants can expect to have their surgical outcomes monitored, and their experiences will contribute to understanding which method might be more effective and cost-efficient for sterilization during C-sections.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • request for permanent sterilization at the time of cesarean delivery
- • 24 weeks' gestation or beyond
- • 21 years old or older
- • Medicaid sterilization consent per Virginia Department of Medical Assistance Services regulations (if Medicaid recipient).
- Exclusion Criteria:
- • vaginal delivery
- • history of prior adnexal surgery (such as prior bilateral tubal ligation or unilateral salpingectomy oophorectomy)
- • placenta accreta spectrum
- • placenta previa
- • history of bleeding diathesis.
About Inova Health Care Services
Inova Health Care Services is a leading healthcare organization dedicated to providing high-quality, patient-centered care across a comprehensive range of medical specialties. With a commitment to advancing clinical research and innovation, Inova actively sponsors and conducts clinical trials aimed at improving health outcomes and enhancing treatment options for patients. The organization combines state-of-the-art facilities, a skilled team of medical professionals, and a robust research infrastructure to facilitate groundbreaking studies that address pressing health challenges. Through its dedication to excellence in clinical research, Inova Health Care Services strives to contribute to the evolving landscape of healthcare and improve the lives of individuals in the communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Falls Church, Virginia, United States
Patients applied
Trial Officials
Jean W Thermolice, MD
Principal Investigator
Inova Fairfax Medical Campus
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported